"US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024" was originally created and ...

A new study published in the New England Journal of Medicine showed that improvements in symptoms and quality of life were ...

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement ...

The Global Transcatheter Cardiac Valve Replacement (THVR) Market, valued at USD 6.54 billion in 2023, is anticipated to grow significantly with a CAGR of 14.8% over the forecast period of 2024 to 2032 ...

In a trial that many are calling landmark, transcatheter aortic valve replacement had better outcomes than surveillance for ...

For patients with symptomatic and severe tricuspid regurgitation (TR), tricuspid transcatheter edge-to-edge repair (T-TEER) ...

The NOTION-3 study investigated if routine revascularization with PCI and transcatheter aortic valve replacement improves ...

Data regarding outcomes after percutaneous transcatheter tricuspid-valve replacement are needed. In this international, multicenter trial, we randomly assigned 400 patients with severe symptomatic ...

Data from randomized trials examining whether early intervention with transcatheter aortic-valve replacement (TAVR) will improve outcomes in these patients are lacking. At 75 centers in the United ...

Patients with cryptogenic stroke treated with routine transcatheter patent foramen ovale closure have increased 4-year stroke risk.

Implantation of the Ventura interatrial shunt, while safe, does not improve clinical outcomes or prognosis in patients with HF and preserved LVEF.